These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 16153751

  • 1. A review of vaccine research and development: tuberculosis.
    Girard MP, Fruth U, Kieny MP.
    Vaccine; 2005 Dec 30; 23(50):5725-31. PubMed ID: 16153751
    [Abstract] [Full Text] [Related]

  • 2. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep 30; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 3. Tuberculosis vaccine research: the impact of immunology.
    Barker LF, Brennan MJ, Rosenstein PK, Sadoff JC.
    Curr Opin Immunol; 2009 Jun 30; 21(3):331-8. PubMed ID: 19505813
    [Abstract] [Full Text] [Related]

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 30; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 5. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 30; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 6. What's new in tuberculosis vaccines?
    Ginsberg AM.
    Bull World Health Organ; 2002 Dec 30; 80(6):483-8. PubMed ID: 12132007
    [Abstract] [Full Text] [Related]

  • 7. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.
    Dietrich J, Doherty TM.
    APMIS; 2009 May 30; 117(5-6):440-57. PubMed ID: 19400867
    [Abstract] [Full Text] [Related]

  • 8. Vaccine strategies against latent tuberculosis infection.
    Andersen P.
    Trends Microbiol; 2007 Jan 30; 15(1):7-13. PubMed ID: 17141504
    [Abstract] [Full Text] [Related]

  • 9. Development of vaccines against tuberculosis.
    Tyagi AK, Nangpal P, Satchidanandam V.
    Tuberculosis (Edinb); 2011 Sep 30; 91(5):469-78. PubMed ID: 21334259
    [Abstract] [Full Text] [Related]

  • 10. Exploring functional genomics for the development of novel intervention strategies against tuberculosis.
    Rachman H, Kaufmann SH.
    Int J Med Microbiol; 2007 Nov 30; 297(7-8):559-67. PubMed ID: 17467338
    [Abstract] [Full Text] [Related]

  • 11. Is a new tuberculosis vaccine necessary and feasible? A Cuban opinion.
    Sierra VG.
    Tuberculosis (Edinb); 2006 Nov 30; 86(3-4):169-78. PubMed ID: 16677860
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tuberculosis subunit vaccine development: impact of physicochemical properties of mycobacterial test antigens.
    Sable SB, Plikaytis BB, Shinnick TM.
    Vaccine; 2007 Feb 19; 25(9):1553-66. PubMed ID: 17166640
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tuberculosis: from genome to vaccine.
    de Jonge MI, Brosch R, Brodin P, Demangel C, Cole ST.
    Expert Rev Vaccines; 2005 Aug 19; 4(4):541-51. PubMed ID: 16117711
    [Abstract] [Full Text] [Related]

  • 18. Genomic study of Mycobacterium tuberculosis and its clinical applications.
    Tyagi JS, Sharma D.
    Indian J Pediatr; 2002 Nov 19; 69 Suppl 1():S29-38. PubMed ID: 12501923
    [Abstract] [Full Text] [Related]

  • 19. Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity.
    Sable SB, Kalra M, Verma I, Khuller GK.
    Clin Immunol; 2007 Mar 19; 122(3):239-51. PubMed ID: 17208519
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.